Stanford University
Showing 16,201-16,300 of 37,038 Results
-
Yong Yean Kim
Assistant Professor of Pediatrics ( Hematology & Oncology)
BioOur lab is interested in translational science to bring new therapies to clinical trials. In particular, we are interested in pediatric sarcomas which have not had advancement in clinical treatment for decades. Current projects in the lab focus on understanding of the biology of fusion transcription factor PAX3::FOXO1 which is the driver mutation in fusion positive rhabdomyosarcoma. PAX3::FOXO1 is a powerful oncogenic transcription factor which rewires the transcriptional organization to lock the cancer cell in the proliferative state. Since transcription factors including PAX3::FOXO1 are difficult to target using small molecules, we aim to understand how PAX3::FOXO1 is regulated and targeting the regulators of PAX3::FOXO1. By understanding and targeting the regulation of PAX3::FOXO1, we hope to bring new therapies for fusion positive rhabdomyosarcoma. Additionally, these regulatory mechanisms may also be active in other transcription driven cancers such as the EWSR1::FLI1 driven Ewings Sarcoma.
Our lab is also interested in exploring the epigenetic landscape of pediatric solid tumors and trying to understand how dysregulation in the epigenome drives oncogenesis. We utilize various CRISPR mediated genetic techniques to interrogate the regulators of epigenome focusing on the histone lysine demethylases (KDMs). KDMs are an understudied group of epigenetic regulators which can be targeted for therapeutic effect. We explore the role of KDMs in pediatric solid tumors and hope to identify potential targets for drug development. -
Youn H Kim, MD
The Joanne and Peter Haas, Jr., Professor for Cutaneous Lymphoma Research and Professor, by courtesy, of Medicine (Oncology)
Current Research and Scholarly InterestsClinical research in cutaneous lymphomas, especially, mycosis fungoides; studies of prognostic factors, long-term survival results, and effects of therapies. Collaborative research with Departments of Pathology and Oncology in basic mechanisms of cutaneous lymphomas. Clinical trials of new investigative therapies for various dermatologic conditions or clinical trials of known therapies for new indications.
-
Sara Elizabeth Kimberlin
Sr. Research Senior Scholar
BioSara Kimberlin is a Postdoctoral Scholar at the Stanford Center on Poverty and Inequality. Her research interests include alternative approaches to conceptualizing and measuring poverty, and the effects and effectiveness of anti-poverty policies.
-
Samuel Kimmey
Casual - Non-Exempt, Pathology Operations supported expenses #2
BioSam Kimmey is a PhD candidate in the Bendall Lab. He grew up in Upstate New York and studied Biochemistry as an undergraduate at Stony Brook University.
-
Mia Kimura
Events Manager, Chief of Staff
BioMia Kimura is an Events Manager in the Strategy and Communications unit of the Office of the Dean of the School of Medicine.
-
Kevin Kinast
Health & Safety Specialist, Environmental Health and Safety (EH&S)
Current Role at StanfordSupervise Waste Programs with the Environmental Protection Program
-
Benyam Z. Kinde, MD, PhD
Assistant Professor of Ophthalmology
BioDr. Kinde is a board-certified, fellowship-trained ophthalmologist and ophthalmic plastic and reconstructive surgeon at Stanford Health Care Byers Eye Institute. He is also an assistant professor in the Department of Ophthalmology at Stanford University School of Medicine. Dr. Kinde completed the American Society of Ophthalmic and Plastic Reconstructive Surgery (ASOPRS) fellowship in ophthalmic plastic surgery through the Bascom Palmer Eye Institute at the University of Miami.
Dr. Kinde diagnoses and treats a wide range of conditions related to the eyelid and other eye structures, including facial nerve palsy, skin cancer, and thyroid eye disease. He also provides care for patients who wish to enhance their appearance through surgical and nonsurgical interventions. Dr. Kinde offers many types of treatments, including cosmetic surgery, eyelid surgery (including upper and lower eyelid blepharoplasty and ptosis surgery), reconstructive surgery, tear duct (lacrimal) surgery, and orbital surgery.
Dr. Kinde is a physician-scientist whose research interests focus on developing new tools to promote survival of retinal ganglion cells after optic nerve injury. He has investigated how modulating the DNA damage response in mouse models of traumatic optic neuropathy (symptoms of nerve damage) may promote and improve optic nerve function after injury. His previous work focused on increasing the resilience of neurons (messaging nerve cells) in mouse models of glaucoma and in humans with glaucoma. He completed his MD and PhD in neuroscience at Harvard Medical School, where his thesis work revealed a new understanding of Rett syndrome, a rare genetic disorder that affects body movement.
Dr. Kinde has published in many peer-reviewed journals, including Nature, Science, Cell, Ophthalmology, and Facial Plastic Surgery & Aesthetic Medicine. He has presented to his peers at international and national meetings, including the Association for Research in Vision and Ophthalmology, American Society of Ophthalmic Plastic and Reconstructive Surgery, and Inter-American Course in Clinical Ophthalmology. -
Christian Kindermann
Research Engineer, Computational Medicine
Current Role at StanfordI am a research engineer specializing in semantic technologies (ontologies and knowledge graphs). My work focuses on helping life-science practitioners and researchers manage their data.
-
Abby C. King
David and Susan Heckerman Professor and Professor of Epidemiology & Population Health and of Medicine (Stanford Prevention Research Center)
On Partial Leave from 05/01/2026 To 04/30/2027Current Research and Scholarly InterestsMy interests include applications of behavioral theory and social ecological approaches to achieve large scale changes impacting chronic disease prevention and control; expanding the reach and translation of evidence-based interventions through state-of-the-art technologies; exploring social and physical environmental influences on health; applying community participatory research perspectives to address health disparities; and policy-level approaches to health promotion/disease prevention.
-
Jennifer King
HAI Privacy and Data Policy Fellow
Current Research and Scholarly InterestsI research information privacy from the user's perspective (HCI) across multiple domains, including: online commercial contexts, IoT/Ubicomp, human genetics. I conduct both theoretical and applied privacy research, with a focus on the impacts of law and policy on privacy. My dissertation research explored the effects of social structures (such as power differentials) on individuals' decisions to disclose personal information in commercial contexts.
-
Lindsay King
Head Librarian, Art and Architecture Library
Current Role at StanfordHead Librarian, Bowes Art and Architecture Library
-
Roy King
Associate Professor of Psychiatry and Behavioral Sciences, Emeritus
Current Research and Scholarly InterestsCurrent research centers on the use of human genetic haploid systems, e.g. the Y chromosome, to understand the prehistory of human migrations particularly since the Holocene. This work includes investigating correlations with human symbolic material culture, focusing on the visual artistic realm. Also being explored are the issues and ethical implications of the social construction of race and ethnicity vis a vis the enhanced capacity to differentiate populations using genotypes.
-
David Kingsley
Rudy J. and Daphne Donohue Munzer Professor in the School of Medicine
Current Research and Scholarly InterestsWe use mice, stickleback fish, and humans to study the molecular basis of evolution and common diseases. By combining genetics and genomics, we have identified key DNA changes that control bone formation, limb patterning, hair color, brain evolution, and susceptibility to arthritis, schizophrenia, and bipolar disorder. We find that the same genetic mechanisms are often used repeatedly in nature, providing new insights into the origin of key traits in many different species, including ourselves.
-
Valerie Kinsey
Advanced Lecturer
Current Research and Scholarly InterestsSPECIALIZATION: Writing and Critical Thinking Instruction; Institutional Rhetorics; Rhetorics of Race and Gender; Creative Writing; Philosophy and Rhetoric; Historiography; American History and Literature
-
Anthony Kinslow II
Lecturer
BioAnthony, the Founder and CEO of Gemini Energy Solutions, is an expert in energy efficiency analytics and building science and a research-oriented practitioner who utilizes best practices from around the world to develop innovative solutions for his clients. His company's focus is reflective of Anthony's mission in life — making a meaningful impact on mitigating global warming. In Gemini, Anthony has created a vehicle to engage, educate, and energize underrepresented minority communities and the underserved small commercial building market in energy efficiency. Under Anthony’s leadership, Gemini is implementing strategies for overcoming cultural and socio-economic barriers that prevent the vast majority of Americans from being aware or engaged in energy efficiency. Operating nationwide, the company also partners with municipalities — such as San Francisco International Airport and Memphis, TN — to support their efforts to meet their climate change goals and increase economic resiliency through energy efficiency.
Education:
PhD, Stanford University, Civil and Environmental Engineering
MS, Stanford University, Sustainable Design and Construction
BS, North Carolina A&T State University, Civil and Environmental Engineering
Courses:
Racial Equity in Energy
Quest for an Inclusive Clean Energy Economy -
Lucas Kipp
Clinical Associate Professor, Adult Neurology
BioDr. Kipp specializes in the diagnosis and treatment of neuroimmunological disorders, particularly demyelinating conditions such as multiple sclerosis and neuromyelitis optica. He is interested in translational research connecting expert MS clinicians, world-renown immunology laboratories, and advanced neuroimaging techniques to identify biomarkers of disease and treatment response.
-
Sam Kipper
Ph.D. Student in Civil and Environmental Engineering, admitted Summer 2026
BioMy name is Samantha Kipper, and I am a graduate student in Civil and Environmental Engineering. My research focuses on offshore wind energy, and I aim to make the world a better place through technical, sustainable energy solutions.
-
Alaina Kipps
Clinical Professor, Pediatrics - Cardiology
BioDr. Kipps grew up in Santa Cruz, California and completed her medical degree at Harvard Medical School in 2003. After general pediatrics residency at Stanford, she completed pediatric cardiology fellowship at Boston Children’s Hospital from 2006 to 2009. After three years on faculty with University of California, San Francisco she was recruited back to Stanford in 2012 to become the medical director for acute care cardiology (2013-2021). Since 2021 she has focused on QI for the ACCU and heart center, and has served as the ACCU local improvement team medical director since 2013. In 2014 she co-founded the Pediatric Acute Care Cardiology Collaborative (PAC³) with Nicolas Madsen and co-directed this since inception to spring 2026. PAC³ has 50 participating centers, a registry since 2019 with >150,000 encounters, and is the academic society for the ACCU subspecialty. Her academic focus is in clinical effectiveness and quality improvement science, and she completed her Masters of Science in Epidemiology at Harvard School of Public Health in 2016. Her other significant interest is in teaching, mentorship, and coaching. She is the co-director of the Pediatric residency program scholarly concentration in Quality Improvement, co-leads the Pediatric department peer scholar community (in QI), and has served as a residency coach since 2020.
-
Amanda Kirane, MD, PhD, FACS, FSSO
Associate Professor of Surgery (General Surgery)
BioDr. Kirane is a fellowship-trained, board-certified specialist in complex general surgical oncology. She is an Assistant Professor in the Department of Surgery, Section of Surgical Oncology, at Stanford University School of Medicine. Dr. Kirane serves as Director of Cutaneous Surgical Oncology at the Stanford Cancer Center and her clinical practice focuses on the diagnosis and treatment of melanoma and other skin cancers. She partners closely with patients and families to provide the most effective treatment approach possible. For each patient, she tailors an evidence-based, personalized care plan that is innovative, comprehensive, and compassionate.
Dr. Kirane is Principal Investigator of multiple studies in melanoma and mechanisms of resistance to immunotherapy, with focus on myeloid biology. Her current interests include immune response and novel therapies in melanoma, predictive modeling of patient responses using organoid technology, and translational biomarker development. She has led research into immune therapy for earlier stage melanoma using regionally directed therapy to augment immune response in melanoma and trials in surgical care in melanoma.
The National Institutes of Health, American Society of Clinical Oncology, the Melanoma Research Alliance, and others have funded her research. She has co-authored articles on her discoveries in the Journal of Clinical Investigation, Nature Communications, Nature Genetics, Cancer Research, Journal of Surgical Oncology, Annals of Surgery, Annals of Surgical Oncology, and elsewhere. Topics include intratumoral therapy, biomarker development, macrophage biology in melanoma and immunotheraputic resistance, and patient-derived organoid modeling. Dr. Kirane has presented updates on the management of melanoma and other cancers to her peers at meetings of the American College of Surgeons, Society of Surgical Oncology, and Society for Immunotherapy in Cancer.
Dr. Kirane has earned awards for her achievements in clinical care, research, and scholarship. The Society for Immunotherapy of Cancer, Society of Surgical Oncology, Memorial Sloan Kettering Cancer Center, and other prestigious organizations have honored her work. She is a fellow of the American College of Surgeons (FACS) and Society of Surgical Oncology (FSSO). She is a member of the Society for Immunotherapy of Cancer, American Association of Cancer Research, Society for Melanoma Research, Connective Tissue Oncology Society, Association of Academic Surgeons, and Association of Women Surgeons.
She volunteers her time and expertise on behalf of the Melanoma Research Foundation, members of her community in need, STEM programs for girls, and other initiatives. She also is fellowship trained in Physician Wellness and Wellbeing and teaches somatic technique, mindfulness-based stress reduction, meditation, and breathwork. -
Cindy Kirby
Administrative Associate, Statistics
Current Role at StanfordFaculty Support: Efron, Diaconis, Lai
Department Webmaster
Building Manager
Space Coordinator
Property Administrator
Sustainability Partner
LaTeX Local Expert -
Varvara A. Kirchner
Associate Professor of Surgery (Abdominal Transplantation) and, by courtesy, of Pediatrics
BioDr. Kirchner completed her medical school, surgical residency and multi-organ transplant fellowship in adult and pediatric liver, pancreas, kidney transplantation and total pancreatectomy with islet auto-transplantation at the University of Minnesota. She underwent further training in living donor liver transplantation and hepatobiliary surgery at the Asan Medical Center, Seoul, South Korea. Her clinical practice involves living and deceased donor liver and kidney transplantation in adult and pediatric patients as well as total pancreatectomy with islet auto-transplantation for patients with chronic and acute recurrent pancreatitis. She currently serves as Surgical Director of the Islet Cell Auto-Transplant at Stanford Children’s and Associate Director of the Living Donor Liver Transplant Program at the Division of Abdominal Transplantation. Dr. Kirchner’s research focuses on the biology of aging, cellular and solid organ transplantation. Her specific interests are in auto-islet transplantation, iPSC-derived hepatocyte therapies and liver regeneration. Dr. Kirchner's research on the impact of donor age on generation of iPSC-derived hepatocyte-like cells is supported by the NIA K08 Faculty Development Award. She is an active member of the American Society of Transplant Surgeons and the International Liver Transplantation Society.
-
Anne Kiremidjian
The C.L. Peck, Class of 1906 Professor in the School of Engineering, Emerita
BioKiremidjian’s research focuses in two main areas. The first is in earthquake hazard, risk, and resilience modeling. She works on structural component and systems reliability methods; structural damage evaluation models; and regional damage, loss and casualty estimation methods utilizing geographic information and database management systems for portfolios of buildings or spatially distributed lifeline systems assessment with ground motion and structure correlations. Her current research has focused on the development of time dependent hazard and risk models for resilience evaluation of hospitals, schools and financial instruments. In the area of time dependent risk assessment, she has developed models for damage estimation of deteriorating structures in varying environmental conditions.
The second area of research focuses on the design and implementation of wireless sensor networks for health monitoring of structures under every-day loading conditions, and the development of robust and computationally efficient algorithms for structural damage diagnosis following extreme events that can be embedded in wireless sensing units. The damage algorithms utilize modern data science, machine learning and artificial intelligence methods. -
Karla Kirkegaard
Violetta L. Horton Professor and Professor of Microbiology and Immunology
Current Research and Scholarly InterestsThe biochemistry of RNA-dependent RNA polymerase function, the cell biology of the membrane rearrangements induced by positive-strand RNA virus infection of human cells, and the genetics of RNA viruses, which, with their high error rates, live at the brink of error catastrophe, are investigated in the Kirkegaard laboratory.
-
Nadia Kirmani
MD Student with Scholarly Concentration in Clinical Research / Immunology, expected graduation Spring 2027
Masters Student in Translational Research and Applied Medicine, admitted Autumn 2025BioBS in Biology & BA in English, Duke University (2019)
Honors: Summa Cum Laude, Phi Beta Kappa
Nadia's research interests include targeted cancer therapeutic development and health equity.
